Published in Am J Psychiatry on April 01, 1979
Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals. Bipolar Disord (2008) 1.16
Gene-environment interactions in severe mental illness. Front Psychiatry (2014) 1.09
Predator threat induces behavioral inhibition, pituitary-adrenal activation and changes in amygdala CRF-binding protein gene expression. Psychoneuroendocrinology (2006) 1.03
Life stress and kindling in bipolar disorder: review of the evidence and integration with emerging biopsychosocial theories. Clin Psychol Rev (2011) 0.89
Central gene expression changes associated with enhanced neuroendocrine and autonomic response habituation to repeated noise stress after voluntary wheel running in rats. Front Physiol (2013) 0.84
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research. Int J Neuropsychopharmacol (2016) 0.81
A comparative study of life events in depression and mania. Indian J Psychiatry (1998) 0.76
Kindling of Life Stress in Bipolar Disorder: Effects of Early Adversity. Behav Ther (2016) 0.75
Individualized stress vulnerabilities in manic depressive patients with repeated episodes. J R Soc Med (1988) 0.75
A study of recent life events and their role in the precipitation of mania. Indian J Psychiatry (1995) 0.75
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA (2001) 5.37
A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nat Genet (1994) 2.30
Dysfunctional attitudes in depressed patients before and after clinical treatment and in normal control subjects. Am J Psychiatry (1990) 1.50
Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry (1992) 1.47
A comparison of paroxetine, imipramine and placebo in depressed out-patients. Br J Psychiatry (1991) 1.45
The cyclic dilemma: organic, functional, and environmental interaction in a young teenager. J Am Acad Child Adolesc Psychiatry (1995) 1.39
The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo. Psychopharmacol Bull (1989) 1.34
The Tridimensional Personality Questionnaire in depression: state versus trait issues. J Psychiatr Res (1996) 1.31
The use of lithium in the affective psychoses. Am J Psychiatry (1966) 1.30
Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology (1991) 1.21
Mechanisms of renal lithium handling and their relationship to mineralocorticoids: a dissociation between sodium and lithium ions. J Psychiatr Res (1971) 1.14
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IV. Am J Psychiatry (1994) 1.13
Panic disorder precipitated by exposure to organic solvents in the work place. Am J Psychiatry (1987) 1.12
Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry (1976) 1.11
Evidence for X-linkage in the transmission of manic-depressive illness. JAMA (1972) 1.10
Lithium retention and excretion. The effect of sodium and fluid intake. Arch Gen Psychiatry (1969) 1.09
A study comparing paroxetine placebo and imipramine in depressed patients. J Affect Disord (1993) 1.08
Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry (1974) 1.05
Rapid cycling manic depressive patients. Compr Psychiatry (1978) 1.03
Life events and primary affective illness. Acta Psychiatr Scand (1978) 1.03
Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorder. Science (1970) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
Cyclone '78 in Sri Lanka--the mental health trail. Br J Psychiatry (1981) 1.01
Rubidium: biochemical, behavioral, and metabolic studies in humans. Am J Psychiatry (1973) 1.00
Heritable factors in the severity of affective illness. Biol Psychiatry (1976) 1.00
Repetitive transcranial magnetic stimulation in the treatment of medication-resistant depression: preliminary data. J Nerv Ment Dis (1999) 0.99
Lithium carbonate and plasma cortisol response in the ffective disorders. Arch Gen Psychiatry (1968) 0.98
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry (1992) 0.97
Cardiac sinus node dysfunction during lithium treatment. Am J Psychiatry (1979) 0.97
Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry (1994) 0.96
The life table. A method for analyzing longitudinal studies. Arch Gen Psychiatry (1976) 0.95
Plasma DOPA response to levodopa administration in man: effects of a peripheral decarboxylase inhibitor. Clin Pharmacol Ther (1971) 0.95
Incidence of side effects in patients on long-term lithium therapy. Am J Psychiatry (1980) 0.94
Treatement of excessive weight gain in patients taking lithium. Am J Psychiatry (1976) 0.94
The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord (1996) 0.93
Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry (1978) 0.91
Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol (1995) 0.91
Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis in unipolar recurrent depression. Arch Gen Psychiatry (1975) 0.91
The use of lithium in affective disorders. II. Prophylaxis of depression in chronic recurrent affective disorder. Am J Psychiatry (1968) 0.91
Relationship of childhood physical and sexual abuse to adult bipolar disorder. Bipolar Disord (2000) 0.91
Differential subtyping of depression. Depress Anxiety (2001) 0.90
Lithium carbonate and affective disorders. V: A double-blind study of prophylaxis of depression in bipolar illness. Arch Gen Psychiatry (1976) 0.90
Pattern analysis of antidepressant response to fluoxetine. J Clin Psychiatry (1986) 0.90
Personality traits during depression and after clinical recovery. Br J Psychiatry (1994) 0.89
Clinical and psychological assessment of children of bipolar probands. Am J Psychiatry (1983) 0.89
Lithium erythrocyte: plasma ratio in primary affective disorder. Compr Psychiatry (1978) 0.89
Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique. Am J Psychiatry (1973) 0.89
Lithium carbonate prophylaxis failure. Br J Psychiatry (1976) 0.88
The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry (1973) 0.88
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial. J Clin Psychiatry (2001) 0.88
Relationship between the effectiveness of lithium therapy and family history. Am J Psychiatry (1973) 0.88
Dawn simulation and bright light in the treatment of SAD: a controlled study. Biol Psychiatry (2001) 0.88
Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry (1980) 0.87
Statistical predictions of suicide in depressives. Compr Psychiatry (1980) 0.87
Manic-depressive illness: linkage with the Xg blood group. Am J Psychiatry (1973) 0.87
DSM-III-R personality disorders in a mood and anxiety disorders clinic: prevalence, comorbidity, and clinical correlates. J Affect Disord (1993) 0.87
Rubidium: a potential modifier of affect and behaviour. Nature (1969) 0.87
A systematic review of research on religion in four major psychiatric journals: 1991-1995. J Nerv Ment Dis (1998) 0.87
Relationship between hypomania and personality disorders before and after successful treatment. Am J Psychiatry (1995) 0.86
Morning or evening bright light treatment of winter depression? The significance of hypersomnia. Biol Psychiatry (1991) 0.86
Genetic history as a predictor of lithium response in manic-depressive illness. Lancet (1972) 0.86
The use of lithium in affective disorders. I. Acute endogenous depression. Am J Psychiatry (1968) 0.86
The course of development of mania in patients with recurrent depression. Am J Psychiatry (1976) 0.86
Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients. Am J Psychiatry (1982) 0.85
Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res (1995) 0.85
Onset of response in relation to outcome in depressed outpatients with placebo and imipramine. J Affect Disord (1989) 0.85
Psychopathology in systemic lupus erythematosus. II. Relation to clinical observations, corticosteroid administration, and cerebrospinal fluid C4. Semin Arthritis Rheum (1973) 0.84
Rubidium chloride ingestion by volunteer subjects: initial experience. Psychopharmacologia (1971) 0.84
Relationship between borderline personality disorder and Axis I diagnosis in severity of depression and anxiety. J Clin Psychiatry (1999) 0.84
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry (1998) 0.84
The relationship of atypical lymphocytes, phenothiazines, and schizophrenia. Arch Gen Psychiatry (1966) 0.83
Lithium treatment in older patients. Am J Psychiatry (1979) 0.83
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder. Biol Psychiatry (1991) 0.83
Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. Neuropsychobiology (1988) 0.83
Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis (1983) 0.83
Manic-depressive illness: a comparative study of patients with and without a family history. Br J Psychiatry (1972) 0.83
The role of electrolytes in affective disorders. Sodium, potassium, and lithium ions. Arch Gen Psychiatry (1970) 0.82